Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company has two clinical-stage programs and a second program that is discovery-stage and partnered with another company. Lux... Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company has two clinical-stage programs and a second program that is discovery-stage and partnered with another company. Luxeptinib, its panFMS-like tyrosine kinase 3 / pan-Bruton's tyrosine kinase inhibitor, is enrolling patients in a Phase 1, multicenter, open label, dose-escalation study with expansions to assess the safety, tolerability, PK, and preliminary efficacy of CG-806 in patients with chronic lymphocytic leukemia (CLL/SLL) or non-Hodgkin lymphomas (NHL). HM43239 is an oral potent myeloid kinome inhibitor, targeting a constellation of kinases operative in myeloid malignancies. Show more
SAN DIEGO and TORONTO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (โAptoseโ or the โCompanyโ) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing...
SAN DIEGO and TORONTO, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (โAptoseโ or the โCompanyโ) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing...
SAN DIEGO and TORONTO, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (โAptoseโ or the โCompanyโ) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0075 | 2.02156334232 | 0.371 | 0.399 | 0.3608 | 57820 | 0.38273964 | CS |
4 | -0.0065 | -1.68831168831 | 0.385 | 0.4077 | 0.3405 | 68593 | 0.37632969 | CS |
12 | -0.1615 | -29.9074074074 | 0.54 | 0.5685 | 0.33 | 550203 | 0.40333195 | CS |
26 | -0.8515 | -69.2276422764 | 1.23 | 1.27 | 0.33 | 292614 | 0.45816449 | CS |
52 | -2.4215 | -86.4821428571 | 2.8 | 3.32 | 0.33 | 185841 | 0.75991013 | CS |
156 | -30.8215 | -98.7868589744 | 31.2 | 41.7 | 0.33 | 302551 | 14.08831082 | CS |
260 | -31.1215 | -98.7984126984 | 31.5 | 138.7875 | 0.33 | 777505 | 63.24858803 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.